The present paper aims to summarize the results regarding serum albumin-based nanoparticles (NPs) for drug delivery purposes. In particular, it focuses on the relationship between their preparation techniques and synthesis parameters, as well as their successful clinical application. In spite of the huge amount of consumed material and immaterial sources and promising possibilities, products made from different types of albumin NPs, with the exception of a few, still have not been invented. In the present paper, promising applications of serum albumin nanoparticles (SANPs) for different biomedical purposes, such as carriers, delivery systems and contrast agents, are also discussed. The most frequent utilization of the NPs for certain diseases, i.e., cancer therapy, and future prospects are also detailed in this study.

Gold nanoparticles in aqueous dispersion were prepared using the trisodium citrate reduction method to control the size of particles by changing the concentration of HAuCl₄. The average particle size measured by DLS is higher than that obtained by TEM at a zeta potential of -40 mV. When trisodium citrate concentration is kept constant, the particle size increases with gold concentration. The kinetics of growth was studied and apparent kinetic rate constants were determined at various gold/citrate ratios. Gold nanoparticles were attached to silanized glass surfaces; Au rods were grown (ca. 200 nm) by adding more precursors and the rods’ growth rate was monitored by UV-Vis spectroscopy as well as by AFM. Surface functionalization of gold surface was influenced by cysteine. The surface modification by cysteine at pH=6.0 results in aggregation and the red shift of absorption maximum is nearly 200 nm. When glutathione molecules are bound onto the cysteinelinked Au rods on the glass surface, the spectral shift reaches only an amount of 5–10 nm, because the surface attachment hinders the tendency to aggregate.